Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and... see more

TSX:ONC - Post Discussion

View:
Post by venture009 on Jun 05, 2023 12:53pm

KOL

This boards consensus is the information was positive, only wish the market and the FDA shared the same opinion. Without FDA granting AA ,and why wouldn't they, with such a difficult disease to treat and few options available, or the announcement of a partner or buyout  the response will continue to be muted. This has been the storyline of this company for so many years beginning with the head and neck back in 2008. They just can't get any traction to see the share price rise to the levels required to garner any instutional investor interest or a BP and one wonders why when this boards response is so overwhelmingly positive. Let's hope they are negotiating with more than one BP otherwise the prospects of a happy ending are growing even more remote.  No money to conduct a PIII themselves leaves very few options. This is the reality and they better move quick, time is money.
Comment by Angler101 on Jun 05, 2023 1:37pm
Hey Venture.....I guess you expected a courier from the FDA to show up this morning at Oncy's head office at 9:00 sharp with an Accelerated Approval certificate, and repesentatives from 5 or 6 Big Pharmas would be fighting all weekend with each other on the front lawn for the rights to Pela?...No?...well, then .if you're so sure thst the share price needs to rise exponentially before they& ...more  
Comment by venture009 on Jun 05, 2023 6:43pm
Aren't you the one a month ago prediciting the price would at least double before the KOL? I have been watching and reading the inflated predictions now for far too many years and the result is the same. As far as selling my shares, infact they are really my wife's shares as I sold mine two years ago, we decided at that time it was sink or swim with the remaining since we have lost so much ...more  
Comment by Angler101 on Jun 05, 2023 8:11pm
Yawn......I see....so you and your wife decided the best plan was to soft bash the message boards to try to discourage investors.......sure bud....whatever you say
Comment by Normandt on Jun 05, 2023 10:03pm
009 is mentally retarded,  don't bother with him.   he is in the same team as armedesliar and ubertheclown.   Just read the yahoo forum to get an idea of the level of their understanding.
Comment by Lesalpes29 on Jun 06, 2023 8:13am
Yes Normandt this Venture009 is a FALSE INVESTOR DIRECT FROM YAHOO BORAD! Please we have to stop to talk to him and Bucky!
Comment by Quentin30 on Jun 05, 2023 1:56pm
why wouldn't they. grant AA Venture ?? WEll they need evidence of a surrogate end-point biomarker... I'm hoping that the increased PFS will act as a surrogate for increased OS, thereby allowing ONCY to go for approval on the basis of PFS. but the data needs to mature for that to happen, otherwise, they will need OS as end point, which will take 3-4 years... :-(
Comment by Noteable on Jun 05, 2023 2:29pm
"They" meaning ONCY's Big Pharma acquirer. That's who the 'they" is in this picture.
Comment by Noteable on Jun 05, 2023 2:35pm
and what in the world is a surrogate endpoint biomarker?
Comment by Noteable on Jun 05, 2023 2:43pm
The surrogate endpoints of ORR and PFS have been defined as biomarkers intended to substitute for a clinical endpoint. So ONCY has already defined the biomarkers and have reached them in the Phase 2 Bracelet-1 study. A Phase 3 will receive an Accelerated Approval based on the PFS surrogate endpoint which Big Pharma would be responsible in achieving, followed by OS.
Comment by Quentin30 on Jun 05, 2023 2:58pm
If OS is the end point, ONCY needs solid data to correlate PFS as a surrogate for that... So until they have that correlation, there will be no accelerated approval. thanks for clarifying Noteable... I wonder why the market still seems unimpressed, when you are as happy as a pig in truffle t urds. :-) to da moon... KOL, more like LOL
Comment by Azzak34 on Jun 05, 2023 3:01pm
Haha you are clueless Quento! 
Comment by Noteable on Jun 05, 2023 3:18pm
PFS is correlation enough given the FDA's Accelerated Approval guidelines. Quentin30 it seems that you can't quite keep up.
Comment by Azzak34 on Jun 05, 2023 2:45pm
Haha you really tried to sound like you know stuff, but you don't! 
Comment by Quentin30 on Jun 05, 2023 3:03pm
Azzak, after all the pumping and wishful thinking, ONCY has now spoken, and the market has reacted... you can draw your own conclusion on how giddy the investment community is... but you go ahead and keep dreaming of rainbows and unicorns...  PPS down, again... impressed...?? will you be equally as impressed, when they realise no-one is going to pony up the money for a phase III, not even AN ...more  
Comment by Azzak34 on Jun 05, 2023 3:14pm
Don't be salty because Noteable embarrassed you! Stop using words and Terms you don't understand.  Results are great and I'm very happy about that. Doublet therapy with a ubiquitous drug like Paclitaxel, very happy. 150% efficacy boost to Paclitaxel, very happy. Phase 3 ready in 2 indications, very happy.  Share price will take care of itself.  Read a book and stop ...more  
Comment by Angler101 on Jun 05, 2023 3:39pm
Hey Quentin....you wanna know what's "too funny really" as you put it?.....but I mean too funny really really and truly.....you spent a bunch of your money shorting the stock this morning expecting the bottom to fall out of the share price, but, lol....and here's the even more "too funny really" part...lol....here you are, desperately spewing more bs  trying to con ...more  
Comment by YegJeeber on Jun 05, 2023 10:58pm
Amazing how you can throw sox any words together and not formulate one logical or rational thought.  SMFH
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities